Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00727974 · ClinicalTrials.gov registry record

Genetic Analysis of Children With Cyclic Vomiting Syndrome (CVS) and Migraines

A clinical trial, sponsored by Medical College of Wisconsin.

Completed
Registry status
586
Enrollment target

NCT00727974: Completed study, sponsored by Medical College of Wisconsin.

NCT00727974 is a clinical trial that has completed, run by Medical College of Wisconsin. The registered enrollment target is 586 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00727974 has completed, sponsored by Medical College of Wisconsin.

COMPLETED
Registry status
586 participants
Enrollment target

Study Summary

The purpose of this study is to determine if there are genetic variations that can explain a genetic basis for cyclic vomiting syndrome (CVS).

Trial Details

FieldValue
Enrollment Target 586 participants
Start Date 2008-03-05
Est. Completion 2013-06-12
Medical College of Wisconsin

447 total trials

What the finished NCT00727974 record still lists

NCT00727974 is an observational study that tracks outcomes without assigning an intervention. The registered 586 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00727974 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00727974 about?

NCT00727974 is a clinical study titled "Genetic Analysis of Children With Cyclic Vomiting Syndrome (CVS) and Migraines". The purpose of this study is to determine if there are genetic variations that can explain a genetic basis for cyclic vomiting syndrome (CVS).

What is the current status of trial NCT00727974?

This trial is currently completed. The enrollment target is 586 participants. The study started on 2008-03-05. Estimated completion is 2013-06-12.

Who is sponsoring clinical trial NCT00727974?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04134260 · 586 participants · Phase 3

    Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial

  • NCT06100770 · 586 participants

    Aveir AR Coverage With Evidence Development (CED) Study

  • NCT06183281 · 586 participants · NA

    Integrating Nonpharmacologic Strategies for Pain With Inclusion, Respect, and Equity

  • NCT06976203 · 586 participants · Phase 3

    A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00727974, the US trial registry maintained by the National Library of Medicine. NCT00727974 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.